Preventing depression in the community by voluntary sector providers (PERSUADE): intervention development and protocol for a parallel randomised controlled feasibility trial.
Cognitive Behavioral Therapy
Community Mental Health Services
/ methods
Depression
/ prevention & control
Feasibility Studies
Focus Groups
Humans
Patient Acceptance of Health Care
Patient Selection
Process Assessment, Health Care
Randomized Controlled Trials as Topic
Self-Help Groups
Volunteers
/ education
depression
feasibility
prevention
protocol
sub-threshold
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
03 10 2019
03 10 2019
Historique:
entrez:
6
10
2019
pubmed:
6
10
2019
medline:
21
10
2020
Statut:
epublish
Résumé
Depression is now the most common illness worldwide affecting more than 300 million people. Studies modelling the impact of depression interventions have shown that the burden of depression cannot be minimised by more than 35% with existing treatments. There is a need to develop better preventative interventions. The overall aim of this programme of work is to develop interventions to reduce depression symptom scores and prevent development of depression in people with subthreshold depression. The objectives are to adapt a low intensity community-based depression prevention intervention, establish the acceptability and uptake of this model and conduct a parallel randomised controlled feasibility trial to inform a full-scale trial. Focus groups will be run with members of the public, voluntary sector providers and researchers to inform the adaptation of an existing depression prevention course. Sixty-four people with subthreshold depression, as represented by a score of between 5 and 9 on the Patient Health Questionnaire-9 depression measure, will be recruited to take part in the feasibility trial. Participants will be randomised equally to the intervention or usual care control groups. Participants in the intervention group will receive the new revised manual and attend a 1-day workshop delivered by voluntary sector service providers. Outcome measures will be completed 3 months after baseline. Quantitative data on recruitment, randomisation, attendance, retention, questionnaire completion rates will be collected. Primary analyses will be descriptive and a process evaluation will be conducted to assess the processes involved in implementing the intervention. Interviews will be conducted to explore acceptability and framework analysis will be used to analyse the data. The study has been reviewed and approved by NHS Research and Ethics Committee: NW-Greater Manchester East. The results will be actively disseminated through peer-reviewed journals, conference presentations, social media, the internet and community engagement activities. ISRCTN23278208;Pre-results.
Identifiants
pubmed: 31585966
pii: bmjopen-2018-023791
doi: 10.1136/bmjopen-2018-023791
pmc: PMC6797240
doi:
Banques de données
ISRCTN
['ISRCTN23278208']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e023791Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
PLoS Med. 2009 Oct;6(10):e1000160
pubmed: 19806180
Br J Psychiatry. 2004 Jun;184:526-33
pubmed: 15172947
Clin Psychol Rev. 2009 Jul;29(5):449-58
pubmed: 19450912
Arch Gen Psychiatry. 1998 Aug;55(8):694-700
pubmed: 9707379
J Affect Disord. 2004 Apr;79(1-3):71-9
pubmed: 15023482
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Am Psychol. 2012 May-Jun;67(4):285-95
pubmed: 22583342
Am J Community Psychol. 1995 Apr;23(2):199-222
pubmed: 7572830
Br J Psychiatry. 2007 Apr;190:326-32
pubmed: 17401039
Lancet. 2017 Jan 14;389(10065):186-195
pubmed: 27988144
JAMA. 2012 Mar 14;307(10):1033-4
pubmed: 22416097
Acta Psychiatr Scand. 2007 Mar;115(3):229-36
pubmed: 17302623
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Am J Psychiatry. 2008 Oct;165(10):1272-80
pubmed: 18765483
J Consult Clin Psychol. 2005 Oct;73(5):790-9
pubmed: 16287379
Am J Psychiatry. 2014 Apr;171(4):453-62
pubmed: 24434956
Soc Psychiatry Psychiatr Epidemiol. 2009 Mar;44(3):198-207
pubmed: 18726242
Acta Psychiatr Scand. 2004 May;109(5):325-31
pubmed: 15049768
Stat Med. 2004 Jun 30;23(12):1827-42
pubmed: 15195318
Annu Rev Clin Psychol. 2010;6:181-212
pubmed: 20192789
Int J Epidemiol. 2014 Apr;43(2):318-29
pubmed: 24760873
Br J Psychiatry. 2014 Mar;204(3):222-33
pubmed: 24357574
J Eval Clin Pract. 2004 May;10(2):307-12
pubmed: 15189396
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
J Ment Health Policy Econ. 2000 Mar 1;3(1):3-10
pubmed: 11967432
JAMA. 2016 Dec 27;316(24):2618-2626
pubmed: 28027368
Depress Anxiety. 2008;25(7):632-40
pubmed: 17941095
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Br J Psychiatry. 2004 Dec;185:511-5
pubmed: 15572743
Int J Geriatr Psychiatry. 2003 Sep;18(9):829-38
pubmed: 12949851
Can J Psychiatry. 2004 Feb;49(2):124-38
pubmed: 15065747
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Arch Gen Psychiatry. 2011 Jun;68(6):577-84
pubmed: 21646576
Lancet. 2017 Jan 14;389(10065):176-185
pubmed: 27988143
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Br J Psychiatry. 2013 Jan;202(1):22-7
pubmed: 23284149